---
figid: PMC12224282__WO-29-56058-g002
figtitle: Tumor-associated macrophages and PD-1/PD-L1 networking in colorectal cancer
organisms:
- NA
organisms_ner:
- Homo sapiens
- Danio rerio
pmcid: PMC12224282
filename: WO-29-56058-g002.jpg
figlink: /pmc/articles/PMC12224282/figure/F2/
number: F2
caption: 'The PD-1/PD-L1 pathway in tumor cells, tumor-associated macrophages, and
  T-cells within the tumor microenvironmentImage source: PD-1/PD-L1 pathway: a therapeutic
  target in CD30+ large cell lymphomas ALK – anaplastic lymphoma kinase – a receptor
  tyrosine kinase involved in cell growth; rearrangements are implicated in several
  cancers, EBV – Epstein-Barr Virus – a herpesvirus associated with several malignancies,
  including nasopharyngeal carcinoma and some lymphomas, LMP1 – latent membrane protein
  1 – an EBV-encoded protein with oncogenic properties, MEK/ERK – mitogen-activated
  protein kinase kinase/extracellular signal-regulated kinase – part of a signaling
  pathway that regulates cell division and survival, MHC – major histocompatibility
  complex – a set of genes encoding cell-surface proteins essential for immune recognition,
  TCR – T-cell receptor – a molecule on T-cells that recognizes antigens presented
  by MHC molecules Image source: Xie W, Medeiros LJ, Li S, et al. PD-1/PD-L1 pathway:
  a therapeutic target in CD30+ large cell lymphomas. Biomedicines 2022; 10: 1587'
papertitle: The role of tumor-associated macrophages and PD-1/PD-L1 networking in
  colorectal cancer
reftext: Melina Yerolatsite, et al. Contemp Oncol (Pozn). 2025 May 09;29(2).
year: '2025'
doi: 10.5114/wo.2025.150448
journal_title: Contemporary Oncology
journal_nlm_ta: Contemp Oncol (Pozn)
publisher_name: Termedia Publishing
keywords: colorectal cancer | tumor microenvironment | tumor-associated macrophages
  | PD-1/PD-L1 network
automl_pathway: 0.95819
figid_alias: PMC12224282__F2
figtype: Figure
redirect_from: /figures/PMC12224282__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12224282__WO-29-56058-g002.html
  '@type': Dataset
  description: 'The PD-1/PD-L1 pathway in tumor cells, tumor-associated macrophages,
    and T-cells within the tumor microenvironmentImage source: PD-1/PD-L1 pathway:
    a therapeutic target in CD30+ large cell lymphomas ALK – anaplastic lymphoma kinase
    – a receptor tyrosine kinase involved in cell growth; rearrangements are implicated
    in several cancers, EBV – Epstein-Barr Virus – a herpesvirus associated with several
    malignancies, including nasopharyngeal carcinoma and some lymphomas, LMP1 – latent
    membrane protein 1 – an EBV-encoded protein with oncogenic properties, MEK/ERK
    – mitogen-activated protein kinase kinase/extracellular signal-regulated kinase
    – part of a signaling pathway that regulates cell division and survival, MHC –
    major histocompatibility complex – a set of genes encoding cell-surface proteins
    essential for immune recognition, TCR – T-cell receptor – a molecule on T-cells
    that recognizes antigens presented by MHC molecules Image source: Xie W, Medeiros
    LJ, Li S, et al. PD-1/PD-L1 pathway: a therapeutic target in CD30+ large cell
    lymphomas. Biomedicines 2022; 10: 1587'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ALK
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - CD274
  - PDLIM7
  - EPHB2
  - MAPK1
  - MAPK3
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - TRBV20OR9-2
  - TRA
  - TRB
  - TRD
  - TRG
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - HLA-C
  - alk
  - ltk
  - stat1b
  - stat4
  - si:ch211-241b2.5
  - pak2a
  - itpka
  - inhibitors
---
